Amgen And LabCentral Open Nomination Process For Lab Residency

Opportunity for Life Sciences and Biotech Startups to Submit Proposal to Win Golden Ticket CAMBRIDGE, Mass., Oct. 6, 2017 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and LabCentral today announced that the nomination process to submit proposals to receive an Amgen-sponsored LabCentral Golden Ticket is open for interested life sciences and biotech startup companies. LabCentral is an innovative, shared laboratory space designed as a launchpad for premier high-impact life sciences and biotech startups. As one of LabCentral's platinum sponsors, Amgen can nominate up to two early-stage companies each year to take up residence in LabCentral's Kendall Square facilities in Cambridge, Mass. "Openin...
Source: Amgen News Release - Category: Pharmaceuticals Tags: Uncategorized Source Type: news